Cipla, Indian’s third-largest drug company, is the frontrunner to acquire various business divisions of ailing Wockhardt, according to a report from financial portal Moneycontrol. “Cipla is in pole position currently and is leading the race to buy a clutch of Wockhardt's business divisions which have been put on the block," Moneycontrol quoted an unidentified source as saying.
Cipla, led by Yusuf Hamied, “can achieve further scale and boost its domestic presence with this transaction. The discussions are...
